Outset Medical (OM) Shareholder's Equity Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Outset Medical | 90,946.35 | -286.55 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.25% |
| Dec 31, 2025 | 373.37% |
| Sep 30, 2025 | 197.70% |
| Jun 30, 2025 | 125.64% |
| Mar 31, 2025 | 82.26% |
| Dec 31, 2024 | -78.18% |
| Sep 30, 2024 | -68.55% |
| Jun 30, 2024 | -62.54% |
| Mar 31, 2024 | -56.91% |
| Dec 31, 2023 | -50.04% |
| Sep 30, 2023 | -45.52% |
| Jun 30, 2023 | -40.89% |
| Mar 31, 2023 | -37.39% |
| Dec 31, 2022 | -34.24% |
| Sep 30, 2022 | -31.88% |
| Jun 30, 2022 | -28.16% |
| Mar 31, 2022 | 12.66% |
| Dec 31, 2021 | 13.84% |
| Sep 30, 2021 | 15.64% |
| Jun 30, 2021 | 229.06% |
| Mar 31, 2021 | 199.45% |
| Dec 31, 2020 | 188.29% |
| Sep 30, 2020 | 200.36% |
| Dec 31, 2019 | -29.25% |